methylprednisolone has been researched along with Bone Diseases, Metabolic in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.26) | 18.7374 |
| 1990's | 3 (15.79) | 18.2507 |
| 2000's | 9 (47.37) | 29.6817 |
| 2010's | 6 (31.58) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bouxsein, ML; Brooks, DJ; Chandler, H; Hattersley, G; Lanske, B | 1 |
| Achiou, Z; Boudenot, A; Lespessailles, E; Ominsky, MS; Pallu, S; Toumi, H; Touvier, J; Uzbekov, R | 1 |
| Bhadauria, S; Chattopadhyay, N; China, SP; Gayen, JR; Godbole, MM; Gupta, SK; Hossain, Z; Khan, K; Mandalapu, D; Mittal, M; Pal, S; Porwal, K; Sanyal, S; Sharma, VL; Shrivastava, R; Taneja, I; Trivedi, AK; Wahajuddin, M | 1 |
| Fontanella, V; Mahl, CR | 1 |
| Asadi, F; Rassouli, A; Rezaian, M; Shomali, T | 1 |
| Cai, DH; Chen, H; Deng, WM; He, L; Li, QN; Sun, P; Yang, L | 1 |
| Conaghan, PG; Emery, P; Haugeberg, G; Morton, S | 1 |
| Balal, M; Binokay, F; Demir, E; Erken, U; Kurt, C; Paydas, S; Sertdemir, Y; Sikgenc, MM | 1 |
| de Deus, RB; Ferreira, AC; Heilberg, IP; Kirsztajn, GM | 1 |
| Fukushima, S; Kokubo, S; Miyata, K; Nozaki, K; Takahashi, K; Teramura, K | 1 |
| Bosco, A; Bratina, A; Cazzato, G; Giuntini, D; Locatelli, L; Nasuelli, D; Rudick, RA; Tommasi, MA; Toncic, M; Zivadinov, R; Zorzon, M | 1 |
| Iwamoto, J; Sato, Y; Seki, A; Shen, CL; Takeda, T; Yamada, H; Yeh, JK | 1 |
| Hoshino, T; Koida, M; Nakamuta, H; Nitta, T | 1 |
| Náfrádi, L; Toldy, E; Varga, L | 1 |
| Fukushima, T; Koida, M; Nakamuta, H; Nitta, T | 1 |
| Huzita, T; Nakayama, Y; Ozaki, D; Shirai, Y; Yoshihara, K | 1 |
| Fujita, T; Fukuyama, R; Furuichi, H; Izumo, N; Kohno, T; Koida, M; Nakamuta, H | 1 |
| Braith, RW; Edwards, DG; Fricker, FJ; Howard, C; Mitchell, M | 1 |
| Beghe, F; Di Giuseppe, P; Di Munno, O; Favini, P; Occhipinti, G; Pasero, G; Pontrandolfo, A | 1 |
3 trial(s) available for methylprednisolone and Bone Diseases, Metabolic
| Article | Year |
|---|---|
Effect of intra-articular corticosteroid injections and inflammation on periarticular and generalised bone loss in early rheumatoid arthritis.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Bone Density; Bone Diseases, Metabolic; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Injections, Intra-Articular; Male; Metacarpophalangeal Joint; Methotrexate; Methylprednisolone; Middle Aged; Treatment Outcome | 2011 |
[Measure of bone loss in rheumatoid arthritis].
Topics: Adrenal Cortex Hormones; Adult; Arthritis, Rheumatoid; Bone Diseases, Metabolic; Densitometry; Female; Humans; Male; Methotrexate; Methylprednisolone; Middle Aged; Osteoporosis; Osteoporosis, Postmenopausal | 1999 |
Prevention of glucocorticoid-induced osteopenia: effect of oral 25-hydroxyvitamin D and calcium.
Topics: Administration, Oral; Aged; Aged, 80 and over; Blood Sedimentation; Bone and Bones; Bone Diseases, Metabolic; Calcifediol; Calcium; Female; Glucocorticoids; Humans; Male; Methylprednisolone; Middle Aged; Polymyalgia Rheumatica | 1989 |
16 other study(ies) available for methylprednisolone and Bone Diseases, Metabolic
| Article | Year |
|---|---|
Abaloparatide increases bone mineral density and bone strength in ovariectomized rabbits with glucocorticoid-induced osteopenia.
Topics: Absorptiometry, Photon; Animals; Biomechanical Phenomena; Bone Density; Bone Density Conservation Agents; Bone Diseases, Metabolic; Female; Femur; Glucocorticoids; Lumbar Vertebrae; Methylprednisolone; Ovariectomy; Parathyroid Hormone-Related Protein; Rabbits; X-Ray Microtomography | 2019 |
Sclerostin antibody and interval treadmill training effects in a rodent model of glucocorticoid-induced osteopenia.
Topics: Animals; Antibodies; Apoptosis; Biomechanical Phenomena; Bone Density; Bone Diseases, Metabolic; Bone Morphogenetic Proteins; Bone Remodeling; Caspase 3; Collagen Type I; Disease Models, Animal; Femur; Genetic Markers; Male; Methylprednisolone; Osteocalcin; Osteocytes; Peptides; Physical Conditioning, Animal; Rats; Rats, Wistar; X-Ray Microtomography | 2015 |
Theophylline, a methylxanthine drug induces osteopenia and alters calciotropic hormones, and prophylactic vitamin D treatment protects against these changes in rats.
Topics: Animals; Apoptosis; Biomarkers; Bone Diseases, Metabolic; Bone Marrow; Bone Regeneration; Calcifediol; Cell Culture Techniques; Cyclic AMP; Dose-Response Relationship, Drug; Female; Fractures, Bone; Male; Methylprednisolone; Osteoblasts; Parathyroid Hormone; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Theophylline; Time Factors; Vitamin D | 2016 |
Evaluation by digital subtraction radiography of induced changes in the bone density of the female rat mandible.
Topics: Animals; Anti-Inflammatory Agents; Bone Density; Bone Density Conservation Agents; Bone Diseases, Metabolic; Etidronic Acid; Female; Image Processing, Computer-Assisted; Mandible; Mandibular Diseases; Methylprednisolone; Methylprednisolone Acetate; Radiographic Image Enhancement; Random Allocation; Rats; Rats, Wistar; Risedronic Acid; Subtraction Technique; Time Factors | 2008 |
Effect of eicosapentaenoic acid on bone changes due to methylprednisolone in rats.
Topics: Alendronate; Animals; Biomarkers; Body Weight; Bone and Bones; Bone Density Conservation Agents; Bone Diseases, Metabolic; Bone Resorption; Dose-Response Relationship, Drug; Eicosapentaenoic Acid; Femur; Glucocorticoids; Injections, Subcutaneous; Male; Methylprednisolone; Osteogenesis; Random Allocation; Rats; Rats, Wistar; Tibia | 2009 |
Effects of alendronate and strontium ranelate on cancellous and cortical bone mass in glucocorticoid-treated adult rats.
Topics: Absorptiometry, Photon; Alendronate; Animals; Bone and Bones; Bone Density; Bone Density Conservation Agents; Bone Diseases, Metabolic; Glucocorticoids; Male; Methylprednisolone; Organometallic Compounds; Rats; Rats, Sprague-Dawley; Thiophenes | 2010 |
Bone disease in renal transplantation and pleotropic effects of vitamin D therapy.
Topics: Azathioprine; Bone Density; Bone Diseases; Bone Diseases, Metabolic; Creatinine; Female; Humans; Kidney Transplantation; Lipids; Male; Methylprednisolone; Mycophenolic Acid; Osteonecrosis; Osteoporosis; Sirolimus; Vitamin D | 2010 |
Osteopenia in patients with glomerular diseases requiring long-term corticosteroid therapy.
Topics: Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents; Bone Density; Bone Diseases, Metabolic; Calcium; Drug Administration Schedule; Female; Femur Neck; Humans; Infusions, Intravenous; Kidney Diseases; Lumbar Vertebrae; Lupus Erythematosus, Systemic; Male; Methylprednisolone; Prednisone; Pulse Therapy, Drug | 2003 |
Effect of incadronate on corticosteroid-induced osteopenia in rats.
Topics: Administration, Oral; Animals; Bone Density; Bone Diseases, Metabolic; Compressive Strength; Diphosphonates; Dose-Response Relationship, Drug; Lumbar Vertebrae; Male; Methylprednisolone; Methylprednisolone Acetate; Rats; Rats, Sprague-Dawley | 2004 |
Long-term effects of intravenous high dose methylprednisolone pulses on bone mineral density in patients with multiple sclerosis.
Topics: Adult; Anti-Inflammatory Agents; Bone Density; Bone Diseases, Metabolic; Female; Femur Neck; Humans; Injections, Intravenous; Lumbosacral Region; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Osteoporosis; Spine; Time | 2005 |
Preventive effects of risedronate and calcitriol on cancellous osteopenia in rats treated with high-dose glucocorticoid.
Topics: Animals; Bone and Bones; Bone Density Conservation Agents; Bone Diseases, Metabolic; Bone Resorption; Calcitriol; Etidronic Acid; Female; Glucocorticoids; Methylprednisolone; Osteogenesis; Random Allocation; Rats; Rats, Sprague-Dawley; Risedronic Acid | 2006 |
Glucocorticoid-induced osteopenia in rats: histomorphometrical and microarchitectural characterization and calcitonin effect.
Topics: Animals; Bone Diseases, Metabolic; Calcitonin; Male; Methylprednisolone; Methylprednisolone Acetate; Rats; Rats, Wistar | 1996 |
Glucocorticoid-induced secondary osteopenia in female rats: a time course study as compared with ovariectomy-induced osteopenia and response to salmon calcitonin.
Topics: Analgesics; Animals; Bone Density; Bone Diseases, Metabolic; Bone Remodeling; Bone Resorption; Calcitonin; Female; Glucocorticoids; Methylprednisolone; Methylprednisolone Acetate; Ovariectomy; Rats; Rats, Wistar; Time Factors | 1999 |
Multiple fish vertebra deformity in child with systemic lupus erythematosus: a case report.
Topics: Anti-Inflammatory Agents; Bone Density; Bone Diseases, Metabolic; Calcitonin; Child; Female; Humans; Hydroxycholecalciferols; Low Back Pain; Lupus Erythematosus, Systemic; Methylprednisolone; Prednisolone; Spinal Curvatures | 2000 |
Bone-anabolic effect of salmon calcitonin on glucocorticoid-induced osteopenia in rats.
Topics: Animals; Bone Development; Bone Diseases, Metabolic; Calcitonin; Female; Male; Methylprednisolone; Methylprednisolone Acetate; Rats; Rats, Wistar | 2000 |
Glucocorticoid-induced osteopenia in adolescent heart transplant recipients.
Topics: Absorptiometry, Photon; Adolescent; Adult; Alkaline Phosphatase; Amino Acids; Bone Density; Bone Diseases, Metabolic; Child; Cross-Sectional Studies; Female; Glucocorticoids; Heart Transplantation; Humans; Male; Methylprednisolone | 2000 |